Overview
- 164 inspections across 149 sites are on record.
- 99 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-07-07.
At a glance
Inspections
164
Sites
149
Observations
99
Career since
Jan 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| James Lilly M.D. | 7 Jul 2026 | Human Drugs | |
| Dr. Andrea Di Cianni | 11 Jun 2026 | Human Drugs | |
| Osteal Therapeutics Inc | 7 May 2026 | Human Drugs | |
| Direct Biologics, LLC | 24 Apr 2026 | Biologics | |
| Sameh Sayfo, MD | 17 Apr 2026 | Medical Devices & Rad Health |
Sites inspected
James Lilly M.D.dallas, United States1 insp.
Dr. Andrea Di CianniBuenos Aires, Argentina1 insp.
Osteal Therapeutics IncDallas, United States1 insp.
Direct Biologics, LLCAustin, United States1 insp.
Sameh Sayfo, MDPlano, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Adam C Hipko5 shared
Terri E Gibson4 shared
Ruth E Medcalf3 shared
Habacuc V Barrera3 shared
Amanda J White3 shared
Janet B Abt3 shared
Iris C Macinnes2 shared
Audrey J Yarbrough2 shared
eNSpect User2 shared
Raman K Kaushal1 shared
Full investigator report
Get the verbatim findings behind Travis M Beard's 99 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site